Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Treatment of recurrent vulvovaginal candidiasis
Autore:
Ringdahl, EN;
Indirizzi:
Univ Missouri, Sch Med, Dept Family & Community Med, Columbia, MO 65201 USA Univ Missouri Columbia MO USA 65201 Community Med, Columbia, MO 65201 USA
Titolo Testata:
AMERICAN FAMILY PHYSICIAN
fascicolo: 11, volume: 61, anno: 2000,
pagine: 3306 - 3312
SICI:
0002-838X(20000601)61:11<3306:TORVC>2.0.ZU;2-T
Fonte:
ISI
Lingua:
ENG
Soggetto:
VULVO-VAGINAL CANDIDIASIS; CANDIDAL VAGINITIS; LACTOBACILLUS-ACIDOPHILUS; BORIC-ACID; CLOTRIMAZOLE; ITRACONAZOLE; KETOCONAZOLE; WOMEN; PROPHYLAXIS; ALBICANS;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
32
Recensione:
Indirizzi per estratti:
Indirizzo: Ringdahl, EN Univ Missouri, Sch Med, Dept Family & Community Med, Columbia, MO 65201 USA Univ Missouri Columbia MO USA 65201 , Columbia, MO 65201 USA
Citazione:
E.N. Ringdahl, "Treatment of recurrent vulvovaginal candidiasis", AM FAM PHYS, 61(11), 2000, pp. 3306-3312

Abstract

Vulvovaginal candidiasis is considered recurrent when at least four specific episodes occur in one year or at least three episodes unrelated to antibiotic therapy occur within one year. Although greater than 50 percent of women more than 25 years of age develop vulvovaginal candidiasis at some time, fewer than 5 percent of these women experience recurrences. Clinical evaluation of recurrent episodes is essential. Patients who self-diagnose may miss other causes or concurrent infections. Known etiologies of recurrent vulvovaginal candidiasis include treatment-resistant Candida species other than Candida albicans, frequent antibiotic therapy, contraceptive use, compromise of the immune system, sexual activity and hyperglycemia. If microscopic examination of vaginal secretions in a potassium hydroxide preparation isnegative but clinical suspicion is high, fungal cultures should be obtained. After the acute episode has been treated, subsequent prophylaxis (maintenance therapy) is important. Because many patients experience recurrences once prophylaxis is discontinued, long-term therapy may be warranted. Patients are more likely to comply when antifungal therapy is administered orally, but oral treatment carries a greater potential for systemic toxicity and drug interactions.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/09/20 alle ore 11:27:08